Fundz

Gen Ep reported raising $4.96 Million in an initial SEC Form D filing, from an offering of $5.31 Million

PRIVATEMay 31, 2023$5M of $5.3M raised

Amount Raised

$4.96 Million

$4.96 Million sold, per SEC Form D (first sale May 17, 2023)

Round Type

Seed

CharlottesvilleBiotechnologyScience And Engineering

Quick answer

GenEp raised $4.96 Million in a Seed round, dated May 17, 2023. GenEp is based in Charlottesville, Virginia, United States.

How much did GenEp raise?
GenEp raised $4.96 Million in a Seed round on May 17, 2023.
What does GenEp do?
GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets.
Where is GenEp based and how big is it?
GenEp is based in Charlottesville, Virginia, United States.
Who are the decision-makers at GenEp?
Fundz holds 1 contact at GenEp. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as GenEp that raised within 45 days of this round, from Fundz verified event records.

  • Septerna raised $73M on June 28, 2023.
  • Feldan Therapeutics raised $17M (Series B) on June 13, 2023.
  • Upstream Bio raised $200M (Series B) on June 8, 2023.
  • Ray Therapeutics raised $14M on May 15, 2023.
  • Antiva Biosciences raised $53M (Series E) on April 27, 2023.
  • Antiva Biosciences raised $27M on April 24, 2023.

Who to call at GenEp, and when

A new round usually means GenEp is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GenEp raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GenEp, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GenEp. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GenEp

Location

Charlottesville, Virginia, United States

About

GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GenEp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for GenEp's next move

See what Strategic adds

GenEp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.